BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Vivanza Biosciences Ltd Industry :  Trading
BSE Code
530057
ISIN Demat
INE984E01035
Book Value (Rs)
1.1
NSE Symbol
N.A
Divident Yield %
0
Market Cap
(Rs In Cr.)
8
P/E (TTM)
14.62
EPS (TTM)
0.13
Face Value
(Rs)
1
Back
Vivanza Biosciences consolidated net profit rises 400.00% in the December 2025 quarter
12-Feb-26   Hrs IST

Net profit of Vivanza Biosciences rose 400.00% to Rs 0.20 crore in the quarter ended December 2025 as against Rs 0.04 crore during the previous quarter ended December 2024. Sales rose 2916.67% to Rs 45.25 crore in the quarter ended December 2025 as against Rs 1.50 crore during the previous quarter ended December 2024.

ParticularsQuarter Ended
Dec. 2025Dec. 2024% Var.
Sales45.251.50 2917
OPM %0.468.00 -
PBDT0.200.05 300
PBT0.200.04 400
NP0.200.04 400

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)